Floatz logo

Prednisone

Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Fred Hutchinson Cancer CenterSmall moleculePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

15 Active assets in the Chronic Inflammatory Demyelinating Polyradiculoneuropathy cohort.

Asset / SponsorPhaseRating
Amifampridine
National Center for Research Resources (NCRR)
Phase 3BB
Human Immunoglobulins
National Center for Research Resources (NCRR)
Phase 3BB
i10e
Laboratoire français de Fractionnement et de Biotechnologies
Phase 3B
Anti-Human T-Lymphocyte Immunoglobulin, Rabbit
Fred Hutchinson Cancer Center
Phase 2CCC
Cytarabine
Fred Hutchinson Cancer Center
Phase 2CCC

View all 18 →

Same molecule, other indications

Prednisone is also rated in:

B-cell childhood acute lymphoblastic leukemiaDormant
BBB
Indicative · Phase 3
74 / 100
View asset →
diffuse large B-cell lymphomaActive
BBB
Indicative · Phase 4
74 / 100
View asset →
peripheral T-cell lymphoma, not otherwise specifiedActive
BBB
Indicative · Phase 4
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →